We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Intelligent Ultrasound Group Plc | LSE:MED | London | Ordinary Share | GB00BN791Q39 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 14.50 | 14.00 | 15.00 | 0.00 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Jan 2022 to Jan 2025
By Michael Susin
Intelligent Ultrasound Group PLC said Thursday that the U.S. Food and Drug Administration has granted a de novo clearance for clinical use of its AI medical device, ScanNav Anatomy Peripheral Nerve Block.
The company, which uses artificial intelligence in health applications, said that the ScanNav Anatomy PNB product can now be launched into the U.S. anesthesiology ultrasound market.
The company said it seeks to launch the system to the U.S. market shortly, through its existing in-house sales resources.
The clearance follows the FDA's conclusion that there are no devices already on the market that meet the same clinical need, it added.
Intelligent Ultrasound said that the technology supports healthcare professionals by making it easier for them to interpret the ultrasound view of a patient's anatomy.
The company also added that it continues to seek to license an integrated version of the product to major ultrasound manufacturers.
Write to Michael Susin at michael.susin@wsj.com
(END) Dow Jones Newswires
October 20, 2022 04:33 ET (08:33 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year Intelligent Ultrasound Chart |
1 Month Intelligent Ultrasound Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
